You have 9 free searches left this month | for more free features.

Condition

Non-Small Cell Lung Cancer, Ovarian Cancer (1)

Non-Squamous Non-Small Cell Lung Cancer (1)

Ovarian Cancer (1)

Overall Status

Completed (2)

Terminated (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Genentech, Inc. (3)

Collaborator

Intervention

dnib0600a (3)

bevacizumab (1)

carboplatin (1)

pld (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

dnib0600a

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Non-Squamous NSCLC Trial in Boston, Oklahoma City, Nashville (Bevacizumab, Carboplatin, DNIB0600A)

Completed

Non-Squamous Non-Small Cell Lung Cancer

Bevacizumab
+2 more

Boston, Massachusetts
+3 more

Oct 2, 2017

NSCLC, Ovarian Cancer Trial in Spain, United States (DNIB0600A)

Completed

Non-Small Cell Lung Cancer, Ovarian Cancer

DNIB0600A

Scottsdale, Arizona
+6 more

Jun 5, 2017

Ovarian Cancer Trial in Worldwide (DNIB0600A, PLD)

Terminated

Ovarian Cancer

DNIB0600A
PLD

Phoenix, Arizona
+35 more

Aug 17, 2017